DOI RECORD
Efficacy and Safety of Pegylated Liposomal Doxorubicin in Combination With Bortezomib for Multiple Myeloma: Effects of Adverse Prognostic Factors on Outcome
DOI10.3816/clml.2011.n.005
PublisherElsevier BV
Journal / SourceClinical Lymphoma Myeloma and Leukemia
Published2011-02
Metadata Deposited2012-11-13 (updated: 2025-10-31)
Subject—
Languageen
ISSN2152-2650
Typejournal-article
Volume / Issue / Pages11 / 1 / 44-49
Citations35
References deposited18
Access / license metadataRestricted reuse / TDM license License 1 ↗ License 2 ↗A reuse license does not by itself establish whether the full text is freely readable.
Go to Main Website